Publikationen

2024

Bungenberg, J., Hohenfeld, C., Costa, A. S., Heine, J., Schwichtenberg, K., Hartung, T., . . . Reetz, K. (2024). Characteristic functional connectome related to Post-COVID-19 syndrome. Sci Rep, 14(1), 4997. doi:10.1038/s41598-024-54554-3

Ferreira, M., Schaprian, T., Kugler, D., Reuter, M., Deike-Hoffmann, K., Timmann, D., . . . Reetz, K., Romanzetti, S. . . . Faber, J. (2024). Correction: Cerebellar Volumetry in Ataxias: Relation to Ataxia Severity and Duration. Cerebellum. doi:10.1007/s12311-024-01681-2

Haeger, A., Muising, J., Romanzetti, S., Fimm, B., Matz, O., Schulz, J. B., Heim, S., Reetz, K. (2024). Communicative impairment and its neural correlates in Alzheimer's disease and frontotemporal dementia. Brain Behav, 14(3), e3420. doi:10.1002/brb3.3420

Kučikienė, D., Rajkumar, R., Timpte, K., Heckelmann, J., Neuner, I., Weber, Y., & Wolking, S. EEG microstates show different features in focal epilepsy and psychogenic nonepileptic seizures. Epilepsia, n/a(n/a). doi: 10.1111/epi.17897

McColgan, P., Thobhani, A., Boak, L., Schobel, S. A., Nicotra, A., Palermo, G., . . . GENERATION HD1Investigators (2023). Tominersen in Adults with Manifest Huntington's Disease. N Engl J Med, 389(23), 2203-2205. doi:10.1056/NEJMc2300400

Rezende, T. J. R., Adanyaguh, I., Barsottini, O. G. P., Bender, B., Cendes, F., Coutinho, L., deistung, A., Dogan, I., . . . Reetz, K., . . . Harding, I. H. (2024). Genotype-specific spinal cord damage in spinocerebellar ataxias: an ENIGMA-Ataxia study. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2023-332696

Rodriguez-Labrada, R., Canales-Ochoa, N., Galicia-Polo, M. L., Cruz-Rivas, E., Romanzetti, S., Pena-Acosta, A., . . . Dogan, I., . . . Reetz, K. & Velazquez-Perez, L. (2024). Structural Brain Correlates of Sleep Microstructure in Spinocerebellar Ataxia Type 2 and its Role on Clinical Phenotype. Cerebellum. doi:10.1007/s12311-024-01674-1

Weber, N., Buchholz, M., Radke, A., Faber, J., Schmitz-Hubsch, T., Jacobi, H., . . . ESMI study group (2024). Factors Influencing Health-Related Quality of Life of Patients with Spinocerebellar Ataxia. Cerebellum. doi:10.1007/s12311-024-01657-2

2023

Baagil, H., Hohenfeld, C., Habel, U., Eickhoff, S. B., Gur, R. E., Reetz, K.,& Dogan, I. (2023). Neural correlates of impulse control behaviors in Parkinson's disease: Analysis of multimodal imaging data. Neuroimage Clin, 37, 103315. doi:10.1016/j.nicl.2023.103315

Biessels, G. J., & Costa, A. S. (2023). Cerebral Amyloid Angiopathy-How to Translate Updated Diagnostic Criteria for This Multifaceted Disorder to Clinical Practice? JAMA Neurol. doi:10.1001/jamaneurol.2022.5060

Brown, F. S., Glasmacher, S. A., Taylor, D., Jenkins, R., Chandran, S., Gillespie, D., & Foley, P. (2023). Pain and cognitive performance in adults with multiple sclerosis: A systematic review. Mult Scler Relat Disord, 71, 104584. doi:10.1016/j.msard.2023.104584

Buchholz, M., Weber, N., Borel, S., Sayah, S., Xie, F., Schulz, J. B., Reetz, K., . . . Michalowsky, B. (2023). Patient-reported, health economic and psychosocial outcomes in patients with Friedreich ataxia (PROFA): protocol of an observational study using momentary data assessments via mobile health app. BMJ Open, 13(8), e075736. doi:10.1136/bmjopen-2023-075736

Costa, A. S., Balloff, C., Bungenberg, J., Tauber, S. C., Telke, A. K., Bandlow, C., . . . Schulz, J. B., . . . Reetz, K., . . . Albrecht, P. (2023). Cognitive and neuropsychiatric trajectories up to one year after mild to severe COVID-19. Psychiatry Res, 327, 115375. doi:10.1016/j.psychres.2023.115375

David, S., Hohenfeld, C., Haberl, L. M., Pahl, J., Costa, A. S., Kilders, A., Hildebrand, F., Schulz, J. B., Reetz, K., & Haeger, A. (2023). Physical activity monitoring in Alzheimer's disease during sport interventions: a multi-methodological perspective. Frontiers in Neurology, 14. doi: 10.3389/fneur.2023.1195694

Faber, J., Berger, M., Wilke, C., Hubener-Schmid, J., Schaprian, T., Santana, M. M., . . . Reetz, K., Dogan, I., . . . Klockgether, T. (2023). Stage-dependent biomarker changes in spinocerebellar ataxia type 3. Ann Neurol. doi:10.1002/ana.26824

Faber J, Berger M, Carlo W, Hübener-Schmid J, Schaprian T, Santana MM, Grobe-Einsler M, Onder D, Koyak B, Giunti P, Garcia-Moreno H, Gonzalez-Robles C, Lima M, Raposo M, Vieira Melo AR, de Almeida LP, Silva P, Pinto MM, van de Warrenburg BP, van Gaalen J, Jeroen de Vries J, Oz G, Joers JM, Synofzik M, Schöls L, Riess O, Infante J, Manrique L, Timmann D, Thieme A, Jacobi H, Reetz K, Dogan I, Onyike C, Povazan M, Schmahmann J, Ratai EM, Schmid M, Klockgether T. Stage-dependent biomarker changes in spinocerebellar ataxia type 3. medRxiv [Preprint]. 2023 Apr 25:2023.04.21.23287817. doi: 10.1101/2023.04.21.23287817

Ferreira, M., Schaprian, T., Kügler, D., Reuter, M., Deike-Hoffmann, K., Timmann, D.,. . . Reetz, K., Romanzetti, S., . . . Faber, J. (2023). Cerebellar volumetry in ataxias: Relation to ataxia severity and duration. Res Sq. doi:10.21203/rs.3.rs-3605029/v1

van Gils, V., Ramakers, I., Jansen, W. J., Banning, L., Kučikienė, D., Costa, A. S., Schulz, J. B. , . . . Reetz, K., Vos, S. J. B. (2023). Contributions of Vascular Burden and Amyloid Abnormality to Cognitive Decline in Memory Clinic Patients. Journal of Alzheimer's Disease Reports, 7, 1299-1311. doi:10.3233/ADR-230040

Glasmacher, S. A. & Reetz, K. (2023). Aktuelle pharmakologische krankheitsmodifizierende Therapieansätze bei der Huntington-Krankheit. DGNeurologie Retrieved from https://link.springer.com/article/10.1007/s42451-023-00582-8

Heine J., Hartung, T. J., Rekers, S., Chien, C., Boesl, F., Rust, R., Hohenfeld, C., Bungenberg, J., Costa, A. S., Scheibenbogen, C., Bellmann-Strobl, J., Paul, F., Franke, C., Reetz, K., Finke, C. (2023). Structural brain changes in patients with post-COVID fatigue: a prospective observational study. eClinicalMedicine. doi:10.1016/j.eclinm.2023.101874

Hengel, H., Martus, P., Faber, J., Giunti, P., Garcia-Moreno, H., Solanky, N., . . . Reetz, K., . . . Schols, L. (2023). Correction to: The frequency of non‑motor symptoms in SCA3 and their association with disease severity and lifestyle factors. J Neurol. doi:10.1007/s00415-023-12064-8

Indelicato, E., Reetz, K., Maier, S., Nachbauer, W., Amprosi, M., Giunti, P., Mariotti, C., Durr, A., de Rivera Garrido, F. J. R., Klopstock, T., Schöls, L., Klockgether, T., Bürk, K., Pandolfo, M., Didszun, C., Grobe-Einsler, M., Nanetti, L., Nenning, L., Kiechl, S., Dichtl, W., … Schulz, J. B., … European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) (2023). Predictors of Survival in Friedreich's Ataxia: A Prospective Cohort Study. Movement disorders : official journal of the Movement Disorder Society, 10.1002/mds.29687. doi: 10.1002/mds.29687

Kasper, J., Eickhoff, S. B., Caspers, S., Peter, J., Dogan, I., Wolf, R. C., Reetz, K., . . . Orth, M. (2023). Local synchronicity in dopamine-rich caudate nucleus influences Huntington's disease motor phenotype. Brain. doi:10.1093/brain/awad043

Pinho, J., Almeida, F. C., Araujo, J. M., Machado, A., Costa, A. S., Silva, F., . . . Oliveira, T. G. (2023). Sex-Specific Patterns of Cerebral Atrophy and Enlarged Perivascular Spaces in Patients with Cerebral Amyloid Angiopathy and Dementia. AJNR Am J Neuroradiol. doi:10.3174/ajnr.A7900

Porcu, L., Fichera, M., Nanetti, L., Rulli, E., Giunti, P., Parkinson, M. H., Didszun, C., . . . Schulz, J. B., Reetz, K., . . . EFACTS Study Group (2023). Longitudinal changes of SARA scale in Friedreich ataxia: Strong influence of baseline score and age at onset. Ann Clin Transl Neurol. doi:10.1002/acn3.51886

Saft, C., Burgunder, J. M., Dose, M., Jung, H. H., Katzenschlager, R., Priller, J., . . . Reetz, K., . . . Landwehrmeyer, G. B. (2023). Differential diagnosis of chorea (guidelines of the German Neurological Society). Neurol Res Pract, 5(1), 63. doi:10.1186/s42466-023-00292-2

Saft, C., Burgunder, J. M., Dose, M., Jung, H. H., Katzenschlager, R., Priller, J., . . . Reetz, K., . . . Landwehrmeyer, G. B. (2023). Symptomatic treatment options for Huntington's disease (guidelines of the German Neurological Society). Neurol Res Pract, 5(1), 61. doi:10.1186/s42466-023-00285-1

Santana, M. M., Gaspar, L. S., Pinto, M. M., Silva, P., Adao, D., Pereira, D., . . ., Reetz, K., . . . de Almeida, L. P. (2023). A standardized protocol for blood and cerebrospinal fluid collection and processing for biomarker research in ataxia. Neuropathol Appl Neurobiol, e12892. doi:10.1111/nan.12892

Schumann-Werner, B., Becker, J., Nikoubashman, O., Wiesmann, M., Schulz, J. B., Reich, A., Pinho, J., & Werner, C. J. (2023). The relationship between neurogenic dysphagia, stroke-associated pneumonia and functional outcome in a cohort of ischemic stroke patients treated with mechanical thrombectomy. J Neurol. doi:10.1007/s00415-023-11940-7

van Eimeren, T., Giehl, K., Reetz, K., Sampaio, C., & Mestre, T. A. (2023). Neuroimaging biomarkers in Huntington's disease: Preparing for a new era of therapeutic development. Parkinsonism Relat Disord, 105488. doi:10.1016/j.parkreldis.2023.105488

Wong, C., Gregory, J., Liao, J., Egan, K., Vesterinen, H. M., Khan, A. A, Anwar, M., …, Glasmacher, S. A, …, Macleod, M. (2023). Systematic, comprehensive, evidence-based approach to identify neuroprotective interventions for motor neuron disease: using systematic reviews to inform expert consensus. BMJ Open. doi:10.1136/bmjopen-2022-064169

Yosypyshyn, D., Kucikiene, D., Ramakers, I., Schulz, J. B. for the Alzheimer's Disease Neuroimaging, Reetz, K., & Costa, A. S. (2023). Clinical characteristics of patients with suspected Alzheimer's disease within a CSF Ass-ratio grey zone. Neurol Res Pract, 5(1), 40. doi:10.1186/s42466-023-00262-8

2022

Michels J., Werner C. J., Schumann-Werner B., Schulz J. B., Costa A. S. and Reetz K.Why cognitive training is important for the health status in Parkinson's disease: preliminary evidence from a clinical three-weeks multidisciplinary intervention.Neurol Res Pract.2022. 4.1. doi: 10.1186/s42466-022-00210-y

Rezende T. J. R., Adanyeguh I. M., Arrigoni F., Bender B., Cendes F., Corben L. A., Deistung A., Delatycki M., Dogan I., Egan G. F., Goricke S. L., Georgiou-Karistianis N., Henry P. G., Hutter D., Jahanshad N., Joers J. M., Lenglet C., Lindig T., Martinez A. R. M., Martinuzzi A., Paparella G., Peruzzo D., Reetz K., Romanzetti S., Schols L., Schulz J. B., Synofzik M., Thomopoulos S. I., Thompson P. M., Timmann D., Harding I. H. and Franca M. C., Jr.Progressive Spinal Cord Degeneration in Friedreich's Ataxia: Results from ENIGMA-Ataxia.Mov Disord.2022. doi: 10.1002/mds.29261

Schumann-Werner B., Schaefer S., Schramm S., Patel H. J., Binkofski F. C. and Werner C. J.Neural Correlates of Oral Stereognosis-An fMRI Study.Dysphagia.2022. doi: 10.1007/s00455-022-10517-2

Cabeza-Ruiz R., Velazquez-Perez L., Perez-Rodriguez R. and Reetz K.ConvNets for automatic detection of polyglutamine SCAs from brain MRIs: state of the art applications.Med Biol Eng Comput.2022. doi: 10.1007/s11517-022-02714-w

Faber J., Kugler D., Bahrami E., Heinz L. S., Timmann D., Ernst T. M., Deike-Hofmann K., Klockgether T., van de Warrenburg B., van Gaalen J., Reetz K., Romanzetti S., Oz G., Joers J. M., Diedrichsen J., Group E. M. S. and Reuter M.CerebNet: A fast and reliable deep-learning pipeline for detailed cerebellum sub-segmentation.Neuroimage.2022. 264.doi: 10.1016/j.neuroimage.2022.119703

Georgiou-Karistianis N., Corben L. A., Reetz K., Adanyeguh I. M., Corti M., Deelchand D. K., Delatycki M. B., Dogan I., Evans R., Farmer J., Franca M. C., Gaetz W., Harding I. H., Harris K. S., Hersch S., Joules R., Joers J. J., Krishnan M. L., Lax M., Lock E. F., Lynch D., Mareci T., Muthuhetti Gamage S., Pandolfo M., Papoutsi M., Rezende T. J. R., Roberts T. P. L., Rosenberg J. T., Romanzetti S., Schulz J. B., Schilling T., Schwarz A. J., Subramony S., Yao B., Zicha S., Lenglet C. and Henry P. G.A natural history study to track brain and spinal cord changes in individuals with Friedreich's ataxia: TRACK-FA study protocol.PLoS One.2022. 17.11. doi: 10.1371/journal.pone.0269649

Haeger A., Boumezbeur F., Bottlaender M., Rabrait-Lerman C., Lagarde J., Mirzazade S., Krahe J., Hohenfeld C., Sarazin M., Schulz J. B., Romanzetti S. and Reetz K.3T sodium MR imaging in Alzheimer's disease shows stage-dependent sodium increase influenced by age and local brain volume.Neuroimage Clin.2022. 36.doi: 10.1016/j.nicl.2022.103274

Hengel H., Martus P., Faber J., Giunit P., Garcia-Moreno H., Solanky N., Klockgether T., Reetz K., van de Warrenburg B. P., Santana M. M., Silva P., Cunha I., de Almeida L. P., Timmann D., Infante J., de Vries J., Lima M., Pires P., Bushara K., Jacobi H., Onyike C., Schmahmann J. D., Hubener-Schmid J., Synofzik M., European Spinocerebellar Ataxia Type-3/Machado-Joseph Disease Initiative Study Group. and Schols L.The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors.J Neurol.2022. doi: 10.1007/s00415-022-11441-z

Hohenfeld C., Terstiege U., Dogan I., Giunti P., Parkinson M. H., Mariotti C., Nanetti L., Fichera M., Durr A., Ewenczyk C., Boesch S., Nachbauer W., Klopstock T., Stendel C., Rodriguez de Rivera Garrido F. J., Schols L., Hayer S. N., Klockgether T., Giordano I., Didszun C., Rai M., Pandolfo M., Rauhut H., Schulz J. B. and Reetz K. Prediction of the disease course in Friedreich ataxia.Sci Rep.2022. 12.1. doi: 10.1038/s41598-022-23666-z

Pandolfo M., Reetz K., Darling A., Rodriguez de Rivera F. J., Henry P. G., Joers J., Lenglet C., Adanyeguh I., Deelchand D., Mochel F., Pousset F., Pascual S., Van den Eede D., Martin-Ugarte I., Vila-Brau A., Mantilla A., Pascual M., Martinell M., Meya U. and Durr A.Efficacy and Safety of Leriglitazone in Patients With Friedreich Ataxia: A Phase 2 Double-Blind, Randomized Controlled Trial (FRAMES).Neurol Genet.2022. 8.6. doi: 10.1212/NXG.0000000000200034

Usnich T., Olmedillas M., Schell N., Paul J. J., Curado F., Skobalj S., Csoti I., Ertan S., Gruber D., Zittel S., Sammler E., Isaacson S. H., Kuhn A. A., Pedrosa D. J., Reetz K., Kasten M., Rolfs A., Bauer P., Skrahina V., Klein C., Bruggemann N. and Group L. S.Frequency of non-motor symptoms in Parkinson's disease patients carrying the E326K and T369M GBA risk variants.Parkinsonism Relat Disord.2022. 107.doi: 10.1016/j.parkreldis.2022.105248

Bungenberg J., Costa A. S. and Reetz K.Von symptombasierter Diagnostik hin zu einem biologischen Konzept - Prodromale Stadienkonzepte der neurodegenerativen Demenzen. NeuroTransmitter. 2022.3 doi: 10.1007/s15016-022-9371-2

Häger A. and Dafotakis M.Mein einer Fuß ist so warm.Klinische Neurophysiologie.2022. 53. doi: 10.1055/a-1710-1162

Kucikiene D., Costa A. S., Banning L. C. P., van Gils V., Schulz J. B., Ramakers I., Verhey F. R. J., Vos S. J. B. and Reetz K.The Role of Vascular Risk Factors in Biomarker-Based AT(N) Groups: A German-Dutch Memory Clinic Study.J Alzheimers Dis.2022. doi: 10.3233/JAD-215391

Wilke C., Mengel D., Schols L., Hengel H., Rakowicz M., Klockgether T., Durr A., Filla A., Melegh B., Schule R., Reetz K., Jacobi H. and Synofzik M.Levels of Neurofilament Light at the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type 1.Neurology.2022. doi: 10.1212/WNL.0000000000200257

Doppler K., Mammadova S., Kuzkina A., Reetz K., Michels J., Hermann W., Sommerauer M., Volkmann J., Oertel W. H., Janzen A. and Sommer C.Association between probable REM sleep behavior disorder and increased dermal alpha-synuclein deposition in Parkinson's disease.Parkinsonism Relat Disord.2022. 99.doi: 10.1016/j.parkreldis.2022.05.010

Glasmacher S. A., Kearns P. K., Hassan Z., Connick P., Tauber S., Reetz K., Foley P., Chandran S. and Future M. S. C.The influence of disease-modifying therapy on hidden disability burden in people with newly diagnosed relapsing-remitting multiple sclerosis.Mult Scler Relat Disord.2022. 63.doi: 10.1016/j.msard.2022.103837

Hess P. P., Ventura Ferreira M. S., Rolles B., Kirschner M., Holtbernd F., Tometten M., Brummendorf T. H. and Beier F.Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1).Clin Case Rep.2022. 10.5. doi: 10.1002/ccr3.5766

Krahe J., Dogan I., Didszun C., Mirzazade S., Haeger A., J Shah N., Giordano I. A., Klockgether T., Madelin G., Schulz J. B., Romanzetti S. and Reetz K.Increased brain tissue sodium concentration in Friedreich ataxia: A multimodal MR imaging study.Neuroimage Clin.2022. 34.doi: 10.1016/j.nicl.2022.103025

Fortmeier K., Hußmann K., Costa A. S., Reetz K. and Heim S.Erprobung des MEC-Tests bei kognitiven Kommunikationsstörungen bei leichten kognitiven Beeinträchtigungen und demenziellen Erkrankungen.Neurologie & Rehabilitation.2022. 28.2. doi: 10.14624/NR2202009

Husch S., Schauermann J., Fimm B., Haubrich C., Reetz K., Schulz J. B. and Maier A.Effect of strength training on orthostatic hypotension in Parkinson's disease-a pilot study.Clin Auton Res.2022. 32.3. doi: 10.1007/s10286-022-00870-5

2021

Haeger A., Bottlaender M., Lagarde J., Porciuncula Baptista R., Rabrait-Lerman C., Luecken V., Schulz J. B., Vignaud A., Sarazin M., Reetz K., Romanzetti S. and Boumezbeur F.What can 7T sodium MRI tell us about cellular energy depletion and neurotransmission in Alzheimer's disease?Alzheimers Dement.2021. 17.11. doi: 10.1002/alz.12501

Haeger A., Pouzat C., Luecken V., N'Diaye K., Elger C., Kennerknecht I., Axmacher N. and Dinkelacker V.Face Processing in Developmental Prosopagnosia: Altered Neural Representations in the Fusiform Face Area.Front Behav Neurosci.2021. 15.doi: 10.3389/fnbeh.2021.744466

Eickhoff C. R., Hoffstaedter F., Caspers J., Reetz K., Mathys C., Dogan I., Amunts K., Schnitzler A. and Eickhoff S. B.Advanced brain ageing in Parkinson's disease is related to disease duration and individual impairment.Brain Commun.2021. 3.3. doi: 10.1093/braincomms/fcab191

Ophey A., Wolfsgruber S., Roeske S., Polcher A., Spottke A., Frolich L., Hull M., Jessen F., Kornhuber J., Maier W., Peters O., Ramirez A., Wiltfang J., Liepelt-Scarfone I., Becker S., Berg D., Schulz J. B., Reetz K., Wojtala J., Kassubek J., Storch A., Balzer-Geldsetzer M., Hilker-Roggendorf R., Witt K., Mollenhauer B., Trenkwalder C., Wittchen H. U., Riedel O., Dodel R., Wagner M. and Kalbe E.Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: Implications for neuropsychological assessments.Alzheimers Dement (Amst).2021. 13.1. doi: 10.1002/dad2.12223

Usnich T., Vollstedt E. J., Schell N., Skrahina V., Bogdanovic X., Gaber H., Forster T. M., Heuer A., Koleva-Alazeh N., Csoti I., Basak A. N., Ertan S., Genc G., Bauer P., Lohmann K., Grunewald A., Schymanski E. L., Trinh J., Schaake S., Berg D., Gruber D., Isaacson S. H., Kuhn A. A., Mollenhauer B., Pedrosa D. J., Reetz K., Sammler E. M., Valente E. M., Valzania F., Volkmann J., Zittel S., Bruggemann N., Kasten M., Rolfs A., Klein C. and Group L. S.LIPAD (LRRK2/Luebeck International Parkinson's Disease) Study Protocol: Deep Phenotyping of an International Genetic Cohort.Front Neurol.2021. 12.doi: 10.3389/fneur.2021.710572

Harding I. H., Chopra S., Arrigoni F., Boesch S., Brunetti A., Cocozza S., Corben L. A., Deistung A., Delatycki M., Diciotti S., Dogan I., Evangelisti S., Franca M. C., Jr., Goricke S. L., Georgiou-Karistianis N., Gramegna L. L., Henry P. G., Hernandez-Castillo C. R., Hutter D., Jahanshad N., Joers J. M., Lenglet C., Lodi R., Manners D. N., Martinez A. R., Martinuzzi A., Marzi C., Mascalchi M., Nachbauer W., Pane C., Peruzzo D., Pisharady P. K., Pontillo G., Reetz K., Rezende T. J., Romanzetti S., Sacca F., Scherfler C., Schulz J. B., Stefani A., Testa C., Thomopoulos S. I., Timmann D., Tirelli S., Tonon C., Vavla M., Egan G. F. and Thompson P. M.Brain Structure and Degeneration Staging in Friedreich Ataxia: MRI Volumetrics from the ENIGMA-Ataxia Working Group.Ann Neurol.2021. doi:10.1002/ana.26200

Hubener-Schmid J., Kuhlbrodt K., Peladan J., Faber J., Santana M. M., Hengel H., Jacobi H., Reetz K., Garcia-Moreno H., Raposo M., van Gaalen J., Infante J., Steiner K. M., de Vries J., Verbeek M. M., Giunti P., Pereira de Almeida L., Lima M., van de Warrenburg B., Schols L., Klockgether T., Synofzik M., European Spinocerebellar Ataxia Type-3/Machado-Joseph Disease Initiative Study G. and Riess O.Polyglutamine-Expanded Ataxin-3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral Blood.Mov Disord.2021. doi: 10.1002/mds.28749

Lillig R., Ophey A., Schulz J. B., Reetz K., Wojtala J., Storch A., Liepelt-Scarfone I., Becker S., Berg D., Balzer-Geldsetzer M., Kassubek J., Hilker-Roggendorf R., Witt K., Mollenhauer B., Trenkwalder C., Roeske S., Wittchen H. U., Riedel O., Dodel R. and Kalbe E.A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic "CERAD-Plus" tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE study.Parkinsonism Relat Disord.2021. 90.doi: 10.1016/j.parkreldis.2021.07.034

Pinho J., Quintas-Neves M., Dogan I., Reetz K., Reich A. and Costa A. S.Incident stroke in patients with Alzheimer's disease: systematic review and meta-analysis.Sci Rep.2021. 11.1. doi: 10.1038/s41598-021-95821-x

Rodriguez-Labrada R., Batista-Izquierdo A., Gonzalez-Melix Z., Reynado-Cejas L., Vazquez-Mojena Y., Sanz Y. A., Canales-Ochoa N., Gonzalez-Zaldivar Y., Dogan I., Reetz K. and Velazquez-Perez L.Cognitive Decline Is Closely Associated with Ataxia Severity in Spinocerebellar Ataxia Type 2: a Validation Study of the Schmahmann Syndrome Scale.Cerebellum.2021. doi: 10.1007/s12311-021-01305-z

J. Koch, K. Willemsen, I. Dogan, R. Rolke, J. B. Schulz, J. Schiefer, K. Reetz and A. Maier.Quantitative sensory testing and norepinephrine levels in REM sleep behaviour disorder - a clue to early peripheral autonomic and sensory dysfunction?J Neurol.2021. doi: 10.1007/s00415-021-10675-7

B. Schumann-Werner, I. Dogan, S. Mirzazade, B. Mall, R. Overbeck, P. Honrath, J. B. Schulz, K. Reetz and C. J. Werner.Clinical predictors and neural correlates for compromised swallowing safety in Huntington disease.Eur J Neurol.2021. doi: 10.1111/ene.14953

Jennifer Faber, Tamara Schaprian, Koyak Berkan, Kathrin Reetz, Marcondes Cavalcante França, Thiago Junqueira Ribeiro de Rezende, Jiang Hong, Weihua Liao, Bart van de Warrenburg, Judith van Gaalen, Alexandra Durr, Fanny Mochel, Paola Giunti, Hector Garcia-Moreno, Ludger Schoels, Holger Hengel, Matthis Synofzik, Benjamin Bender, Gulin Oz, James Joers, Jereon J. de Vries, Jun-Suk Kang, Dagmar Timmann-Braun, Heike Jacobi, Jon Infante, Richard Joules, Sandro Romanzetti, Jorn Diedrichsen, Matthias Schmid, Robin Wolz, Thomas Klockgether. “Regional Brain and Spinal Cord Volume Loss in Spinocerebellar Ataxia Type 3”. Movement Disorder, 2021. PIMD: 33951232; doi: 10.1002/msd.28610

X. Liu, S. B. Eickhoff, S. Caspers, J. Wu, S. Genon, F. Hoffstaedter, R. B. Mars, I. E. Sommer, C. R. Eickhoff, J. Chen, R. Jardri, K. Reetz, I. Dogan, A. Aleman, L. Kogler, O. Gruber, J. Caspers, C. Mathys and K. R. Patil.Functional parcellation of human and macaque striatum reveals human-specific connectivity in the dorsal caudate.Neuroimage.2021. doi: 10.1016/j.neuroimage.2021.118006

U. Ermis, M. I. Rust, J. Bungenberg, A. Costa, M. Dreher, P. Balfanz, G. Marx, M. Wiesmann, K. Reetz, S. C. Tauber and J. B. Schulz. Neurological symptoms in COVID-19: a cross-sectional monocentric study of hospitalized patients. Neurol Res Pract. 2021. 3.1.2021/03/14. doi: 10.1186/s42466-021-00116-1

H. S. Moreira, A. S. Costa, A. Machado, S. L. Castro, S. G. Vicente and C. F. Lima. Impaired Recognition of Facial and Vocal Emotions in Mild Cognitive Impairment. J Int Neuropsychol Soc. 2021. 2021/03/05. doi:10.1017/S135561772100014X

K. Reetz, I. Dogan, R. D. Hilgers, P. Giunti, M. H. Parkinson, C. Mariotti, L. Nanetti, A. Durr, C. Ewenczyk, S. Boesch, W. Nachbauer, T. Klopstock, C. Stendel, F. J. Rodriguez de Rivera Garrido, C. Rummey, L. Schols, S. N. Hayer, T. Klockgether, I. Giordano, C. Didszun, M. Rai, M. Pandolfo, J. B. Schulz and Efacts study group. Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 4-year cohort study. Lancet Neurol. 2021. 2021/03/27. doi: 10.1016/S1474-4422(21)00027-2

Bahr, F. S.; Gess, B.; Muller, M.; Romanzetti, S.; Gadermayr, M.; Kuhl, C.; Nebelung, S.; Schulz, J. B.; Dohrn, M. F.: "Semi-Automatic Mri Muscle Volumetry to Diagnose and Monitor Hereditary and Acquired Polyneuropathies." Brain Sci 11, no. 2 (Feb 6 2021). https://doi.org/10.3390/brainsci11020202

Ana Sofia Costa, João Pinho, Domante Kučikienė, Arno Reich, Jörg B. Schulz and Kathrin Reetz:“Cerebral Amyloid Angiopathy in Amyloid-Positive Patients from a Memory Clinic Cohort.” Journal of Alzheimer’s Disease, vol. 79, no. 4, pp. 1661-1672, 2021. https://pubmed.ncbi.nlm.nih.gov/33492291

Charisse D., Erus G., Pomponio R., Gorges M., Schmidt N., Schneider C., Liepelt-Scarfone I., Riedel O., Reetz K., Schulz J. B., Berg D., Storch A., Witt K., Dodel R., Kalbe E., Kassubek J., Hilker-Roggendorf R. and Baudrexel S.Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease.Neurobiol Aging.2021. 109.doi: 10.1016/j.neurobiolaging.2021.08.020

Brcina N., Hohenfeld C., Heidbreder A., Mirzazade S., Krahe J., Wojtala J., Binkofski F., Schulz J. B., Schiefer J., Reetz K. and Dogan I.Increased neural motor activation and functional reorganization in patients with idiopathic rapid eye movement sleep behavior disorder.Parkinsonism Relat Disord.2021. 92.doi: 10.1016/j.parkreldis.2021.10.019

Hengel H., Martus P., Faber J., Garcia-Moreno H., Solanky N., Giunti P., Klockgether T., Reetz K., van de Warrenburg B. P., Pereira de Almeida L., Santana M. M., Januario C., Silva P., Thieme A., Infante J., de Vries J., Lima M., Ferreira A. F., Bushara K., Jacobi H., Onyike C., Schmahmann J. D., Hubener-Schmid J., Synofzik M. and Schols L.Characterization of Lifestyle in Spinocerebellar Ataxia Type 3 and Association with Disease Severity.Mov Disord.2021. doi: 10.1002/mds.28844

Nikonishyna Y. V., Ortner N. J., Kaserer T., Hoffmann J., Biskup S., Dafotakis M., Reetz K., Schulz J. B., Striessnig J. and Dohrn M. F.Novel CACNA1A Variant p.Cys256Phe Disrupts Disulfide Bonds and Causes Spinocerebellar Ataxia.Mov Disord.2021. doi: 10.1002/mds.28835

2020

P. Honrath, G. Kohls, T. M. Moore, I. Dogan, R. C. Gur, U. Habel, K. Konrad, K. Reetz and R. E. Gur.Investigating Neurocognitive Functioning in Youths With Externalizing Disorders From the Philadelphia Neurodevelopmental Cohort. J Adolesc Health. 2020. 2020/12/16. doi: 10.1016/j.jadohealth.2020.10.029

D. Berg, K. Eggert, B. Haslinger, J. Kassubek, B. Mollenhauer, K. Reetz, A. Rogge, E. Schaeffer, L. Tonges and K. E. Zeuner.Disease modifying treatment trials in Parkinson's disease: how to balance expectations and interests of patients, physicians and industry partners? Neurol Res Pract. 2020. doi: 10.1186/s42466-020-00076-y

A. Thieme, S. Roeske, J. Faber, P. Sulzer, M. Minnerop, S. Elben, H. Jacobi, K. Reetz, I. Dogan, M. Barkhoff, J. Konczak, E. Wondzinski, M. Siebler, O. Mueller, U. Sure, J. D. Schmahmann, T. Klockgether, M. Synofzik and D. Timmann.Validation of a German version of the Cerebellar Cognitive Affective/ Schmahmann Syndrome Scale: preliminary version and study protocol. Neurological Research and Practice. 2020. doi: 10.1186/s42466-020-00071-3

Florian Holtbernd, Sandro Romanzetti, Wolfgang Hermann Oertel, Susanne Knake, Elisabeth Sittig, Anna Heidbreder, Andrea Maier, Janna Krahe, Jennifer Wojtala, Imis Dogan, Jörg Bernhard Schulz, Johannes Schiefer, Annette Janzen, Kathrin Reetz. "Convergent Patterns of Structural Brain Changes in Rapid-eye-movement Sleep Behavior Disorder and Parkinson’s Disease". Sleep. 2020. PMID: 32974664

C. C. Tang, F. Holtbernd, Y. Ma, P. Spetsieris, A. Oh, G. R. Fink, L. Timmermann, C. Eggers and D. Eidelberg; Hemispheric Network Expression in Parkinson's Disease: Relationship to Dopaminergic Asymmetries. J Parkinsons Dis. 2020. 2020/09/15. doi: 10.3233/JPD-202117

F. Holtbernd, S. Romanzetti, W. H. Oertel, S. Knake, E. Sittig, A. Heidbreder, A. Maier, J. Krahe, J. Wojtala, I. Dogan, J. B. Schulz, J. Schiefer, A. Janzen and K. Reetz; Convergent Patterns of Structural Brain Changes in Rapid-eye-movement Sleep Behavior Disorder and Parkinson's Disease. Sleep. 2020. 2020/09/26. doi: 10.1093/sleep/zsaa199

H. Jacobi, S. T. du Montcel, S. Romanzetti, F. Harmuth, C. Mariotti, L. Nanetti, M. Rakowicz, G. Makowicz, A. Durr, M. L. Monin, A. Filla, A. Roca, L. Schols, H. Hengel, J. Infante, J. S. Kang, D. Timmann, C. Casali, M. Masciullo, L. Baliko, B. Melegh, W. Nachbauer, K. Burk-Gergs, J. B. Schulz, O. Riess, K. Reetz and T. Klockgether.Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study. Lancet Neurol. 2020. doi: 10.1016/S1474-4422(20)30235-0

E. Indelicato, W. Nachbauer, A. Eigentler, M. Amprosi, R. Matteucci Gothe, P. Giunti, C. Mariotti, J. Arpa, A. Durr, T. Klopstock, L. Schols, I. Giordano, K. Burk, M. Pandolfo, C. Didszdun, J. B. Schulz, S. Boesch and EFACTS.Onset features and time to diagnosis in Friedreich's Ataxia. Orphanet J Rare Dis. 2020. doi: 10.1186/s13023-020-01475-9

Reetz K, Gess B. 56/m, übergewichtig mit Schmerzen und Gangstörung. DGNeurologie. 2020. doi: 10.1007/s42451-020-00213-6

Liu X, Eickhoff SB, Hoffstaedter F, Genon S, Caspers S, Reetz K, et al. Joint Multi-modal Parcellation of the Human Striatum: Functions and Clinical Relevance. Neurosci Bull. 2020. doi: 10.1007/s12264-020-00543-1

Haeger A, Mangin JF, Vignaud A, Poupon C, Grigis A, Boumezbeur F, Frouin V, Deverre JR, Sarazin M, Hertz-Pannier L, Bottlaender M, the SENIOR Team. Imaging the aging brain: study design and baseline findings of the SENIOR cohort. Alzheimers Res Ther. 2020;12(1):77. Epub 2020/06/28. doi: 10.1186/s13195-020-00642-1. PubMed PMID: 32591008; PMCID: PMC7320588.

Stout J, Hozer F, Coste A, Mauconduit F, Djebrani-Oussedik N, Sarrazin S, Poupon, J., Meyrel, M., Romanzetti, S. et al. Accumulation of Lithium in the Hippocampus of Patients With Bipolar Disorder: A Lithium-7 Magnetic Resonance Imaging Study at 7 Tesla. Biol Psychiatry. 2020. doi: 10.1016/j.biopsych.2020.02.1181

Wilke C, Haas E, Reetz K, Faber J, Garcia-Moreno H, Santana MM, van de Warrenburg B, Hengel H, Lima M, Filla A, Durr A, Melegh B, Masciullo M, Infante J, Giunti P, Neumann M, de Vries J, Pereira de Almeida L, Rakowicz M, Jacobi H, Schule R, Kaeser SA, Kuhle J, Klockgether T, Schols L, group SCAns, Barro C, Hubener-Schmid J, Synofzik M. Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice. EMBO Mol Med. 2020:e11803. Epub 2020/06/09.

Öz G, Harding I, Krahe J, Reetz K. MR Imaging and Spectroscopy in degenerative ataxias: toward multimodal, multisite, multistage monitoring of neurodegeneration. Curr Opin Neurol. 2020, in press

Thieme AG, Roeske S, Faber J, Sulzer P, Minnerop M, Elben S, Jacobi H, Reetz K, Dogan I, Barkhoff M, Konczak J, Wondzinski E, Siebler M, Mueller O, Sure U, Schmahmann JD, Klockgether T, Synofzik M, Timmann D. Validation of a German version of the Cerebellar Cognitive Affective/ Schmahmann Syndrome Scale: preliminary version and study protocol. Neurological Research and Practice 2020

Haeger A, Costa AS, Romanzetti S, Kilders A, Trautwein C, Haberl L, Beulertz M, Hildebrand F, Schulz JB, Reetz K. Effect of a multicomponent exercise intervention on brain metabolism: A randomized controlled trial on Alzheimer's pathology (Dementia‐MOVE). Alzheimer's & Dementia: Translational Research & Clinical Interventions. 2020 May 22;6(1):l4414–9.

Schnellbächer GJ, Hoffstaedter F, Eickhoff SB, Caspers S, Nickl-Jockschadt T, Fox PT, Laird AR, Schulz JB, Reetz K, Dogan I. Functional characterization of atrophy pattern related to cognitive impairment. Frontiers Neurology 2020.

Müller M, Dohrn M, Romanzetti S, Gadermayr M, Reetz K, Krämer NA, Kuhl C, Schulz JB, Gess B. Semi-automated volumetry of MRI serves as a biomarker in neuromuscular patients. Muscle & Nerve. 2020

Hohenfeld C, Kuhn H, Müller C, Nellessen N, Ketteler S, Heinecke A, Goebel R, Shah NJ, Schulz JB, Reske M, Reetz K. Changes in brain activation related to visuo-spatial memory after real-time fMRI neurofeedback training in healthy elderly and Alzheimer's disease. Behavioural Brain Research. 2020, 18:112435.

Krahe J, Binkofski F, Schulz JB, Reetz K*, Romanzetti S*. Neurochemical profiles in hereditary ataxias: A meta-analysis of Magnetic Resonance Spectroscopy studies. Neuroscience & Biobehavioral Reviews 2020, 108:854-865. *shared authorship

Teuber-Hanselmann S, Rekowski J, Vogelsang J, von Armin C, Reetz K, Stang A, Jöckel KH, Wiltfang J, Esselmann H, Otto M, Tumani H, Herring A, Keyvani K. CSF and blodd Kallikrein-8: a promising early biomarker for Alzheimer’s disease. Journal of Neurology, Neurosurgery & Psychiatry (JNNP). 2020; 91(1):40-48.

Stout, J., Hozer, F., Coste, A., Mauconduit, F., Djebrani-Oussedik, N., Sarrazin, S., Poupon, J., Meyrel, M., Romanzetti, S., Etain, B., Rabrait-Lerman, C., Houenou, J., Bellivier, F., Duchesnay, E., & Boumezbeur, F. (2020). Accumulation of Lithium in the Hippocampus of Patients With Bipolar Disorder: A Lithium-7 Magnetic Resonance Imaging Study at 7 Tesla. Biological psychiatry, S0006-3223(20)31293-2. Advance online publication.

Muller, M., M. F. Dohrn, S. Romanzetti, M. Gadermayr, K. Reetz, N. A. Kramer, C. Kuhl, J. B. Schulz and B. Gess (2020). "Semi-automated volumetry of MRI serves as a biomarker in neuromuscular patients."Muscle Nerve.

Schnellbacher, G. J., F. Hoffstaedter, S. B. Eickhoff, S. Caspers, T. Nickl-Jockschat, P. T. Fox, A. R. Laird, J. B. Schulz, K. Reetz and I. Dogan (2020). "Functional Characterization of Atrophy Patterns Related to Cognitive Impairment."Front Neurol 11: 18.

2019

Werner CJ, Krasniqi-Kapiti Z, Hohenfeld C, Schulze F, Hildebrand F, Autschbach R, Floege J, Marx N, Trautwein C, Bruemmendorf TH, Schulz JB, Reetz K, Bollheimer C, Braun GS. Increase in the geriatric Proportion of Patients between 2008-2018 in conservative and operational Subjects of inpatient University Medicine-Implications for Cost and Health Care Structures. 2019. Zeitschrift für Gerontologie und Geriatrie. 52. S143-S143.

Reetz K, Hilgers RD, Isfort S, Dohmen M, Didszun C, Fedosov K, Kistermann J, Mariotti C, Durr A, Boesch S, Klopstock T, Rodríguez de Rivera Garrido Francisci Javier, Schöls L, Klockgether T, Pandolfo M, Korinthenberg R, Lavin P, Molenberghs G, Libri V, Giunti P, Festentsein R, Schulz JB and the EFACTS and NICOFA study group. Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA). Neurological Research and Practice. 2019 in press

Koppers S., C. E., Romanzetti S., Reetz K., Merhof D. (2019). "Sodium Image Denoising Based on a Convolutional Denoising Autoencoder." Bildverarbeitung für die Medizin 2019: 98-103.

Hohenfeld C, Dogan I, Schubert R, Didszun C, Schöls L, Synofzyk, Giordano IA, Klockgether T, Schulz JB, Reilman R, Reetz K. Application of quantitative motor assessments in Friedreich ataxia and evaluation of their relation to clinical measures. Cerebellum. 2019 in press (3.413)

Häger A, Costa AC, Schulz JB, Reetz K. Cerebral changes improved by physical activity during cognitive decline: A systematic review on MRI studies. NeuroImage: Clinical. 2019. (IF 4.45)

Wojtala, J, Heber IA, Neuser P, Heller J, Kalbe E, Rehberg SP, Storch A, Linse K, Schneider C, Gräber S, Berg D, Dams J, Balzer-Geldsetzer M, Hilker R, Oberschmidt C, Witt K, Schmidt N, Deuschl G, Mollenhauer B, Trenkwalder C, Liepelt-Scarfone I, Spottke A, Roeske S, Wüllner U, Wittchen HU, Seifried C, Riedel O, Dodel R, Schulz JB, Reetz K. Dementia in Parkinson’s disease: the impact of the motor phenotype on cognition. Journal of Neurology, Neurosurgery & Psychiatry (JNNP). 2019 (IF 7.35)

Sehlin D, Syvänen S; MINC faculty. Engineered antibodies: new possibilities for brain PET? Eur J Nucl Med Mol Imaging 2019. (IF 7.277)

Arnaldi D, Meles SK, Giuliani A, Morbelli S, Renken RJ, Janzen A, Mayer G, Jonsson C, Oertel WH, Nobili F, Leenders KL, Pagani M, REMPET Study Group. Brain Glucose Metabolism Heterogeneity in Idiopathic REM Sleep Behavior Disorder and in Parkinson's Disease. Journal of Parkinson’s Disease. 2019; 9(1):229-239

Oosterloo M, Bijlsma EK, van Kuijk SM, Minkels F, de Die-Smulders CE; REGISTRY Investigators of the European Huntington's Disease Network; Registry Steering committee; Language coordinators; EHDN's associate site in Singapore. Clinical and genetic characteristics of late-onset Huntington’s disease. Parkinsonism & Related Disorders 2019; 61:101-105.

Hensel L, Hoffstaedter F, Caspers J, Michely J, Mathys C, Heller J, Eickhoff CR, Reetz K, Südmeyer M, Fink GR, Schnitzler A, Grefkes C, Eickhoff SB. Functional connectivity changes of key regions for motor initiation in Parkinson’s disease. Cerebral Cortex. 2019; 29(1): 383-396.

Hopfner, F., S. H. Muller, D. Steppat, J. Miller, N. Schmidt, K. P. Wandinger, F. Leypoldt, D. Berg, A. Franke, W. Lieb, L. Tittmann, M. Balzer-Geldsetzer, S. Baudrexel, R. Dodel, R. Hilker-Roggendorf, E. Kalbe, J. Kassubek, T. Klockgether, I. Liepelt-Scarfone, B. Mollenhauer, P. Neuser, K. Reetz, O. Riedel, C. Schulte, J. B. Schulz, A. Spottke, A. Storch, C. Trenkwalder, H. U. Wittchen, K. Witt, U. Wullner, G. Deuschl and G. Kuhlenbaumer (2019). "No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors." Transl Neurodegener 8: 11.

Costa, A. S., I. Dogan, J. B. Schulz and K. Reetz (2019). "Going beyond the mean: Intraindividual variability of cognitive performance in prodromal and early neurodegenerative disorders." Clin Neuropsychol: 1-21.

Costa, A. S., R. Jokel, A. Villarejo, S. Llamas-Velasco, K. Domoto-Reilley, J. Wojtala, K. Reetz and A. Machado (2019). "Bilingualism in Primary Progressive Aphasia: A Retrospective Study on Clinical and Language Characteristics." Alzheimer Dis Assoc Disord.

Coste, A., F. Boumezbeur, A. Vignaud, G. Madelin, K. Reetz, D. Le Bihan, C. Rabrait-Lerman and S. Romanzetti (2019). "Tissue sodium concentration and sodium T1 mapping of the human brain at 3T using a Variable Flip Angle method." Magn Reson Imaging.

Harshal Jayeshkumar Patel, Sandro Romanzetti, Antonello Pellicano, Michael A. Nitsche, Kathrin Reetz, Ferdinand Binkofski. "Proton Magnetic Resonance spectroscopy of the motor cortex reveals long term GABA change following anodal transcranial Direct Current stimulation”. Scientific Reports. doi:10.1038/s41598-019-39262-7

2018

Wojtala, J, Heber IA, Neuser P, Heller J, Kalbe E, Rehberg SP, Storch A, Linse K, Schneider C, Gräber S, Berg D, Dams J, Balzer-Geldsetzer M, Hilker R, Oberschmidt C, Witt K, Schmidt N, Deuschl G, Mollenhauer B, Trenkwalder C, Liepelt-Scarfone I, Spottke A, Roeske S, Wüllner U, Wittchen HU, Seifried C, Riedel O, Dodel R, Schulz JB, Reetz K. Dementia in Parkinson’s disease: the impact of the motor phenotype on cognition. Journal of Neurology, Neurosurgery & Psychiatry (JNNP). 2018

Balzer-Geldsetzer M, Klotsche J, LANDSCAPE Consortium, Dodel R, Riedel O. Quality of life in a German cohort of Parkinson’s patients assessed with three different measures. Journal of Neurology. 2018

Honrath P, Dogan I, Wudarczyk O, Görlich KS, Votinov M, Werner CJ, Schumann B, Overbeck RT, Schulz JB, Landwehrmeyer BG, Gur RE, Habel U, Reetz K, and the Enroll-HD investigators. Risk factors of suicidal ideation in Huntington’s disease – Literature review and data from Enroll-HD. Journal of Neurology. In press. 2018. 265(11):2548-2561.

Maier A, Dogan I, Heller J, Reh K, Mannartz V, Fandyeyeva V, Koch J, Schulz JB, Schiefer J, Reetz K*, Haubrich C*. Beat-to-beat monitoring in idiopathic REM-sleep behaviour disorder reveals transient orthostatic blood pressure drop. Klinische Neurophysiologie. *shared last authorship

McNulty P, Pilcher R, Ramesh R, Necuiniate R, Hughes A, Farewell D, Holmans P, Jones L, REGISTRY Investigators of the European Huntington’s Diseases Network. Reduced cancer incidence in Huntington’s diseases: Analysis in the Registry Study. J Huntingtons Dis.2018;7(3):209-222

Reetz K, Dogan I, Hohenfeld C, Didszun C, Giunti P, Mariotti C, Durr A, Boesch S, Klopstock T, Rodriguez de Rivera FJ, Schöls L, Giordano I, Bürk K, Pandolfo M, Schulz JB, on behalf the EFACTS study group. Non-ataxia symptoms in Friedreich Ataxia. Report from the Registry of the European Friedreich’s Ataxia Consortium for Translational Studies (EFACTS). Neurology. 2018. 4;91(10):e917-e930.

Stankevich Y, Lueken U, Balzer-Geldsetzer M, Dodel R, Gräber-Sultan S, Berg D, Liepelt-Scarfone I, Hilker-Roggendorf R, Kalbe E, Kaut O, Mollenhauer B, Reetz K, Schäffer E, Schmidt N, Schulz JB, Spottke A, Witt K, Linse K, Storch A, Riedel O. Psychometric Properties of an Abbreviated Version of the Apathy Evaluation Scale for Parkinson Disease (AES-12PD). The American Journal of Geriatric Psychiatry. 2018.

Dogan I, Romanzetti Sandro, Didszun C, Mirzazade S, Timmann D, Saft C, Schöls L, Synofzik M, Giordano AA, Klockgether T, Schulz T. Reetz K. Structural characteristics of the central nervous system in Friedreich Ataxia: An in vivo spinal cord and brain MRI study. Journal of Neurology, Neurosurgery & Psychiatry (JNNP). 2018 Jun 26.

Hohenfeld C, Werner C, Reetz K. Resting-state connectivity in neurodegenerative disorders: is there potential for an imaging biomarker? NeuroImage: Clinical. Elsevier; 2018. 16; 18:849-870.

Heller J, Mirzazade S, Romanzetti S, Habel U, Derntl B, Freitag NM, Schulz JB, Dogan I, Reetz K. Impact of gender and genetics on emotion processing in Parkinson's disease - A multimodal study. NeuroImage: Clinical. Elsevier; 2018. 31; 18:305-314.

Meles SK, Renken RJ, Janzen A, Vadasz D, Pagani M, Arnaldi D, Morbelli S, Nobili F, Mayer G, Leenders KL, Oertel WH; REMPET Study Group. The metabolic pattern if idiopathic REM sleep behavior disorder reflects early-stage Parkinson disease. Journal of Nuclear Medicine. 2018 Sep;59(9):1437-1444.

Reetz K, Rodriguez-Labrada R, Dogan I, Mirzazade S, Romanzetti S, Schulz JB, Cruz-Rivas EM, Alvarez-Cuesta JA, Aguilera Rodriguez R, Gonzalez Zaldivar Y, Auburger G, Velazquez-Perez L. Brain atrophy measures in preclinical and manifest spinocerebellar ataxia type 2. Ann Clin Transl Neurol. 2018. 5, 128-137.

2017

Hohenfeld C, Nellessen N, Dogan I, Kuhn H, Müller C, Papa F, Ketteler S, Goebel R, R, Heinecke A, Shah NJ, Schulz JB, Reske M, Reetz K. Cognitive Improvement and Brain Changes after Real-Time Functional MRI Neurofeedback Training in Healthy Elderly and Prodromal Alzheimer's Disease. Frontiers Neurology 2017

Caspers J, Mathys C, Hoffstaedter F, Südmeyer M, Cieslik EC, Rubbert C, Hartmann CJ, Eickhoff CR, Reetz K, Grefkes C, Michely J, Turowski B, Schnitzler A, Eickhoff SB. Differential functional connectivity alterations of two subdivisions within the right dlPFC in Parkinson’s disease. Frontiers in Human Neuroscience. 2017. 11:288.

Baake, V., Reijntjes, R. H. A. M., Dumas, E. M., Thompson, J. C., REGISTRY Investigators of the European Huntington’s Disease Network, & Roos, R. A. C. (2017). Cognitive decline in Huntington's disease expansion gene carriers. Cortex, 95, 51–62.

Plaschke, R. N., E. C. Cieslik, V. I. Muller, F. Hoffstaedter, A. Plachti, D. P. Varikuti, M. Goosses, A. Latz, S. Caspers, C. Jockwitz, S. Moebus, O. Gruber, C. R. Eickhoff, K. Reetz, J. Heller, M. Sudmeyer, C. Mathys, J. Caspers, C. Grefkes, T. Kalenscher, R. Langner and S. B. Eickhoff (2017). "On the integrity of functional brain networks in schizophrenia, Parkinson's disease, and advanced age: Evidence from connectivity-based single-subject classification." Humann Brain Mapping; 38:5845-5858 (2017). >> pdf

Audrey Tanguy Melac, Caterina Mariotti, Antonie Filipovic Pierucci, Paola Giunti, Javier Arpa, Sylvia Boesch, Thomas Klopstock, Jennifer Müller vom Hagen, Thomas Klockgether, Katrin Bürk, Jörg B Schulz, Kathrin Reetz, Massimo Pandolfo, Alexandra Durr, Sophie Tezenas du Montcel, on behalf of the EFACTS group. Friedreich and dominant ataxias: quantitative differences in cerebellar dysfunction measurments. J Neurol Neurosurg Psychiatry 2017: 0:1-7. doi:10.1136/jnnp-2017-316964.

Anna Pohl, Silke Anders, Hong Chen, Harshal Jayeshkumar Patel, Julia Heller, Kathrin Reetz, Klaus Mathiak and Ferdinand Binkofski. Impaired Emotional Mirroring in Parkinson's Disease - A Study on Brain Activation during Processing of Facial Expressions. Frontiers in Neurology. 2017 Dec 18; doi: 10.3389/fneur.2017.00682.

Meles SK, Vadasz D, Renken RJ, Sitting-Wiegand E, Mayer G, Depboylu C, Reetz K, Overeem S, Pijpers A, Reesink FE, van Laar T, Heinen L, Teune LK, Höffken H, Luster M, Kesper K, Adriaanse SM, Booij J, Leenders KL, Oertel WH. FDG PRT, dopamine transporter SPECT, and olifaction: Combining biomarkers in REM sleepbehavior disorder. Mov Disord. 2017 Jul 22; doi: 10.1002/mds.27094. [Epub ahead of print]

Moss DJH, Pardinas AF, Langbehn D, Lo K, Leavitt BR, Roos R, Durr A, Mead S, Track-Hd investigators, Registry investigators, Holmans P, Jones L, Tabrizi SJ. Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study. The Lancet Neurology. 2017. pii:S1474-4422(17)30161-8.

Lueken U, Evens R, Balzer-Geldsetzer M, Baudrexel S, Dodel R, Gräber-Sultan S, Hilker-Roggendorf R, Kalbe E, Kaut O, Mollenhauer B, Reetz K, Schäffer E, Schmidt N, Schulz JB, Spottke A, Witt K, Linse K, Storch A, Riedel O. Psychometric properties of the apathy evaluation scale in patients with Parkinson's disease. Int J Methods Psychiatr Res. 2017 Apr 18. doi: 10.1002/mpr.1564. [Epub ahead of print]

Lahut S, Gispert S, Ömür Ö, Depboylu C, Seidel K, Domínguez-Bautista JA, et al. Blood RNA biomarkers in prodromal PARK4 and REM sleep behavior disorder show role of complexin-1 loss for risk of Parkinson's disease. Dis Model Mech. 2017 Jan 20;:dmm.028035.

2016

Reetz K, Dogan I, Hilgers RD, Giunti P, Mariotti C, Durr A, Boesch S, Klopstock T, de Rivera FJ, Schöls L, Klockgether T, Bürk K, Pandolfo M, Schulz JB; Progression characteristics of the European Fridreich's Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study. The Lancet Neurology, 2016 Dec; 15 (13) 1346-1354.

Troche MS, Schumann B, Brandimore AE, Okun MS, Hegland KW. Reflex Cough and Disease Duration as Predictors of Swallowing Dysfunction in Parkinson's Disease. Dysphagia. 2016 Jul 26.

Cubo E, Ramos-Arroyo MA, Martinez-Horta S, Martínez-Descalls A, Calvo S, Gil-Polo C; European HD Network. Clinical manifestation of intermediate allele carriers in Huntington disease. Neurology. 2016 Jul 8. pii:10.1212/WNL.2944.

Heller J, Brcina N, Dogan I, Holtbernd F, Romanzetti S, Schulz JB, Schiefer J, Reetz K. Brain imaging findings in idiopathic REM sleep behavior disorder (RBD) - a systematic review on potential biomarkers for neurodegeneration. Sleep Medicine Reviews 2016.

Dogan I, Tinnemann E, Romanzetti S, Mirzazade S, Costa AS, Werner CJ, Heim S, Fedosov K, Schulz S, Timmann D, Giordano IA, Klockgether T, Schulz JB and Reetz K. Cognition in Friedreich’s ataxia: a behavioral and multimodal imaging study. Annals of Clinical and Translational Neurology 2016.

Schrempf W, Katona I, Dogan I, Felbert VV, Wienecke M, Heller J, Maier A, Hermann A, Linse K, Brandt MD, Reichmann H, Schulz JB, Schiefer J, Oertel WH, Storch A, Weis J, Reetz K. Reduced intraepidermal nerve fiber density in patients with REM sleep behavior disorder. Parkinsonism Relat Disord. 2016.

Mengel D, Dams, J, Ziemek J, Becker J, Balzer-Geldsetzer M, Hilker R, Baudrexel S, Kalbe E, Schmidt N, Witt K, Liepelt-Scarfone I, Gräber S, Petrelli A, Neuser P, Schulte C, Wittchen HU, Riedel O, Mollenhauer B, Ebentheuer J, Trenkwalder C, Klockgether T, Spottke A, Wüllner U, Schulz JB, Reetz K, Heber IA, Ramirez A, Dodel R. Apolipoprotein E epsilon4 does not affect cognitive performance in patients with Parkinson's disease. Parkinsonism and Related Disorders 2016; 18:1-18.

Fengler S, Roeske S, Heber I, Reetz K, Schulz JB, Riedel O, Wittchen HU, Baudrexel S, Hilker-Roggendorf R, Mollenhauer B, Witt K, Schmidt N, Balzer-Geldsetzer M, Dams J, Dodel R, Gräber S, Pilotto A, Petrelli A, Fünkele S, Kassubek J, Kalbe E. Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data. Psychological Medicine. 2016:1-2.

Mathys C, Caspers J, Langner R, Südmeyer M, Grefkes C, Reetz K, Moldovan AS, Michely J, Heller J, Rickhoff CR, Turowski B, Schnitzler A, Hoffstaedter F, Eickhoff SB. Functional connectivity differences of the subthalamic nucleus related to Parkinson’s disease. Human Brain Mapping. 2016; 37(3):1235-1253.

2015

Heber IA, Costa AS, Werner CJ, Schöne U, Reich A, Schulz JB, Reetz K; Posterior Cortical Atrophy: A Case Report of a 6-Year Natural Progression.; Alzheimer disease and associated disorders, 2015 p.

Dogan I, Eickhoff CR, Fox PT, Laird AR, Schulz JB, Eickhoff SB, Reetz K. Functional connectivity modeling of consistent cortico-striatal degeneration in Huntington's disease. NeuroImage Clinical. 2015;7:640-52.

Schiefer J, Werner C, Reetz K. Clinical diagnosis and management in early Huntingtons disease: a review. Degenerative Neurological and Neuromuscular Disease. 2015, 5:37-50.

Reetz K, Abbas Z, Costa AS, Gras V, Tiffin-Richards F, Mirzazade S, Holschbach B, Frank RD, Vassiliadou A, Krüger T, Eitner F, Gross T, Schulz JB, Shah NJ. Increased cerebral water content in hemodialysis patients. PloS one. 2015;10(3):e0122188.

New AB, Robin DA, Parkinson AL, Eickhoff CR, Reetz K, Hoffstaedter F, Mathys C, Sudmeyer M, Grefkes C, Larson CR, Ramig LO, Fox PT, Eickhoff SB. The intrinsic resting state voice network in Parkinson's disease. Human brain mapping. 2015; 36(5):1951-1962.

Jauch-Chara K, Binkofski F, Loebig M, Reetz K, Jahn G, Melchert UH, Schweiger U, Oltmanns K. Blunted brain energy consumption relates to insula atrophy and impaired glucose tolerance in obesity. Diabetes. 2015; 64(6):2082-2091.

Reetz K, Dogan I, Costa AS, Dafotakis M, Fedosov K, Giunti P, Parkinson MH, Sweeney MG, Mariotti C, Panzeri M, Nanetti L, Arpa J, Sanz-Gallego I, Durr A, Charles P, Boesch S, Nachbauer W, Klopstock T, Karin I, Depondt C, Vom Hagen JM, Schols L, Giordano IA, Klockgether T, Burk K, Pandolfo M and Schulz JB. Biological and clinical characteristics of the European Friedreich’s Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data. The Lancet Neurology. ; 14(2):174-182.

2014

Baldarçara L, Currie S, Hadjivassiliou M, Hoggard N, Jack A, Jackowski AP, Masclachi M, Parazzini C, Reetz K, Righini A, Schulz JB, Vella A, Webb SJ, Habas C. Consensus Paper: Radiological Biomarkers of Cerebellar Diseases. Cerebellum. Springer US; 2014 Nov 11;1–22.

Tiffin-Richards FE, Costa AS, Holschbach B, Frank RD, Vassiliadou A, Krüger T, Kuckuck Karl, Gross T, Eitner F, Flöge J, Schulz JB, Reetz K. The Montreal Cognitive Assessment (MoCA) - A Sensitive Screening Instrument for Detecting Cognitive Impairment in Chronic Hemodialysis Patients. PLoS ONE; 2014;9(10):e106700.

Ketteler S, Ketteler D, Vohn R, Kastrau F, Schulz JB, Reetz K, Huber W. The processing of lexical ambiguity in healthy ageing and Parkinson's disease: Role of cortico-subcortical networks. Brain Res, 2014;1581: 51-63.

Ana S. Costa, Frances E. Tiffin-Richards, Bernhard Holschbach, Rolf D. Frank, Athina Vassiliadou, Thilo Krüger, Frank Eitner, Theresa Gross, Nadim J. Shah, Jörg B. Schulz, Jürgen Floege and Kathrin Reetz. Clinical Predictors of Individual Cognitive Fluctuations in Patients Undergoing Hemodialysis. YAJKD. 2014; 64(3): 434-442.

Nellessen N, Rottschy C, Eickhoff SB, Ketteler ST, Kuhn H, Shah NJ, et al. Specific and disease stage-dependent episodic memory-related brain activation patterns in Alzheimer's disease: a coordinate-based meta-analysis. Brain Struct Funct. 2014; 220(3):1555-1571.

Heller J, Dogan I, Schulz JB, Reetz K. Evidence for gender differences in cognition, emotion and quality of life in Parkinson’s disease? Aging and Disease, 2014;5(1):63-75.

Clemens B, Voß B, Pawliczek C, Mingoia G, Weyer D, Repple J, Eggermann T, Zerres K, Reetz K, Habel U. Effect of MAOA Genotype on Resting-State Networks in Healthy Participants. Cereb Cortex, 2014; (25/7): 1771-1781.

Werner C, Dogan I, Sass C, Mirzazade S, Schiefer J, Shah NJ, Schulz JB, Reetz K. Altered resting-state connectivity in Huntington's Disease. Hum Brain Mapp 2014;35(6):2582-2593.

Dogan I, Sass C, Mirzazade S, Kleiman A, Werner C, Pohl A, Schiefer J, Binkofski F, Schulz JB, Shah NJ, Reetz K. Neural correlates of impaired emotion processing in manifest Huntington's disease. Soc Cogn Affect Neurosci, 2014; 9(5) 671-680.

2013

Freiherr J, Lundström JN, Habel U, Reetz K. Multisensory integration during aging. Frontiers in Human Neuroscience, 2013;7:863. eCollection.

Hubers AA, van Duijn E, Roos RA, Craufurd D, Rickards H, Landwehrmeyer GB, van der Mast RC, Giltay EJ, REGISTRY investigators of the European Huntington’s Disease Network. Suicidal ideation in a European Huntington’s disease population. Journal of Affective Disorders, 2013;151(1):248-258.

Costa AS, Reich A, Fimm B, Ketteler ST, Schulz JB, Reetz K. Evidence on the sensitivity of the MoCA alternate-forms in monitoring cognitive change in early Alzheimer’s disease. Dement Geriatr Cogn Disord, 2013;37(1-2):95-103.

Jacobi H, Reetz K, Tezenas du Montcel S, Bauer P, Mariotti C, Nanetti L, Rakawicz M, Sulek A, Durr A, Chrales P, Filla A, Antenora A, Schöls L, Schicks J, Infante J, Kang J-S, Timmann D, Di Fabo R, Masciullo M, Baliko L, Bela M, Boesch S, Bürk K, Peltz A, Schultz, JB, Dufaure-Gare I, Klockgether T. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data. Lancet Neurol, 2013;12(7):650-658. *Shared first authorship.

Reetz K, Costa AS, Mirzazade S, Lehmann A, Juzek A, Rakowicz M, Boguslawska R, Schöls L, Linnemann C, Mariotti C, Gristoli M, Dürr A, van de Warrenburg BP, Timmann D, Pandolfo M, Bauer P, Jacobi H, Hauser TK, Klockgether T, Schulz JB; axia Study Group Investigators. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6. Brain, 2013;136(Pt 3):905-917.

Heber IA, Coenen VA, Reetz K, Schulz JB, Hoellig A, Fimm B, Kronenbuerger M. Cognitive effects of deep brain stimulation for essential tremor: evaluation at 1 and 6 years. J Neural Transm, 2013;120(11):1569-1577.

Rottschy C, Kleiman A, Dogan I, Langner R, Mirzazade S, Kronenbuerger M, Werner C, Shah NJ, Schulz JB, Eickhoff SB, Reetz K. Diminished activation of motor working-memory networks in Parkinson’s Disease. PLoS One, 2013;8(4):e61786.

Rottschy C, Caspers S, Roski C, Reetz K, Dogan I, Schulz JB, Zilles K, Laird AR, Fox PT, Eickhoff SB. Differentiated parietal connectivity of frontal regions for "what" and "where" memory. Brain Struct Funct, 2013;218(6):1551-1567.

Dogan I, Eickhoff SB, Schulz JB, Shah NJ, Laird AR, Fox PT, Reetz K. Consistent neurodegeneration and its association with clinical progression in Huntington's disease: A coordinate-based meta-analysis. Neurodegenerative Disorders, 2013;12(1):23-35.

2012

Ertelt D, Witt K, Reetz K, Frank W, Junghanns K, Backhaus J, Tadic V, Pellicano A, Born J, Binkofski F. Skill memory escaping from distraction by sleep-evidence from dual-task performance. PLoS One, 2012; 7(12):e50983.

Reetz K, Romanzetti S, Dogan I, Sass C, Werner CJ, Schiefer J, Schulz JB, Shah NJ. Increased brain tissue sodium concentration in Huntington's Disease - A sodium imaging study at 4T. Neuroimage, 2012;63(1):517-524.

Reetz K, Dogan I, Rolfs A, Binkofski F, Schulz JB, Laird AR, Fox PT, Eickhoff SB. Investigating function and connectivity of morphometric findings - Exemplified on cerebellar atrophy in spinocerebellar ataxia 17 (SCA17). Neuroimage, 2012;62(3):1354-1366.

Costa AS, Fimm B, Friesen P, Soundjock H, Rottschy C, Gross T, Eitner F, Reich A, Schulz JB, Nasreddine ZS, Reetz K. Alternate-form reliability of the montreal cognitive assessment screening test in a clinical setting. Dement Geriatr Cogn Disord, 2012;33(6):379-384.

Rottschy C, Langner R, Dogan I, Reetz K, Laird AR, Schulz JB, Fox PT, Eickhoff SB. Modelling neural correlates of working memory – A coordinate based Meta-Analysis. Neuroimage, 2012;60(1):830-846.

Nickl-Jockschat T, Kleiman A, Schulz JB, Schneider F, Laird AR, Fox PT, Eickhoff SB, Reetz K. Neuroanatomic changes and their association with cognitive decline in mild cognitive impairment: a meta-analysis. Brain Struct Funct, 2012;217(1):115-125.

2011

Reetz K, Kleiman A, Klein C, Lencer R, Zühlke C, Brockmann K, Rolfs A, Binkofski F. CAG repeats determine brain atrophy in Spinocerebellar Ataxia 17: A VBM Study. PloS One, 2011;6(1):e15125.

2010

Brüggemann N, Hagenah J, Reetz K, Schmidt A, Kasten M, Buchmann I, Eckerle S, Bähre M, Münchau A, Djarmati A, von der Vegt J, Siebner HR, Binkofski F, Ramirez A, Behrens M, Klein C. Recessively inherited parkinsonism: Effect of ATP13A2 mutations on the clinical and neuroimaging phenotype. Archives of Neurology, 2010;67(11):1357-1363.

Reetz K, Tadic V, Kasten M, Brüggemann N, Schmidt A, Hagenah J, Pramstaller PP, Ramirez A, Behrens MI, Siebner HR, Klein C, Binkofski F. Structural imaging in the presymptomatic stage of genetically determined parkinsonism. Neurobiol Dis, 2010;39(3):402-408.

Stanley K, Hagenah J, Brüggemann N, Reetz K, Severt L, Klein C, Yu Q, derby C, Pullman, S, Saunders-Pullman, R. Digitized spiral analysis is a promising early motor marker for Parkinson Disease. Parkinsonism Relat Disord, 2010;16(3):233-234.

Reetz K, Lencer R, Hagenah J, Gaser C, Tadic V, Walter U, Wolters A, Steinlechner S, Zühlke C, Brockmann K, Klein C, Rolfs A, Binkofski F. Structural changes associated with progression of motor deficits in spinocerebellar ataxia 17. Cerebellum, 2010;9(2):210-217.

Carbon M, Reetz K, Ghilardi MF, Dhawan V, Eidelberg D. Early Parkinson's Disease: Longitudinal Changes in Brain Activity during Sequence Learning. Neurobiol Dis, 2010;37(2):455-460. *Shared first authorship.

2009

Djarmati A, Hagenah J, Reetz K, Winkler S, Behrens MI, Pawlack H, Lohmann K, Ramirez A, Tadic V, Brüggemann N, Berg D, Siebner HR, Lang AE, Pramstaller PP, Binkofski F, Kostic VS, Gasser T, Klein C. ATP13A2 variants in early-onset Parkinson's disease patients and controls. Mov Disord, 2009;24(14):2104-2111.

Van Nuenen BFL, Weiss MM, Bloem BR, Reetz K, van Eimeren T, Lohmann K, Hagenah J, Pramstaller PP, Binkofski F, Klein C and Siebner HR. Heterozygous carriers of a Parkin or PINK1 mutation share a common functional endophenotype. Neurology, 2009;72(12):1041-1047.

Reetz K, Gaser C, Klein C, Hagenah J, Buchel C, Gottschalk S, Pramstaller PP, Siebner HR, Binkofski F. Structural findings in the basal ganglia in genetically determined and idiopathic Parkinson’s disease. Movement Disorders, 2009;24(1): 99-103.

Rief W, Nestoriuc Y, von Lilienfeld-Toal A, Dogan I, Schreiber F, Hofmann SG, Barsky AJ, Avorn J. Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis. Drug Saf. 2009;32(11):1041-56.

Kontakt

Notfall Schlaganfall

Sprechstunden